Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.
about
Acknowledged signatures of matrix metalloproteinases in Takayasu's arteritisEffects of monocyte-endothelium interactions on the expression of type IV collagenases in monocytes.Decreased PGE₂ content reduces MMP-1 activity and consequently increases collagen density in human varicose vein.The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets.Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser.Reverse Regulatory Pathway (H2S / PGE2 / MMP) in Human Aortic Aneurysm and Saphenous Vein Varicosity.Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.Protein Kinase C Inhibitors as Modulators of Vascular Function and their Application in Vascular DiseaseMatrix metalloproteinases as drug targets in preeclampsiaMatrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodelingPhosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse.Nrf2 signalling and autophagy are involved in diabetes mellitus-induced defects in the development of mouse placenta.Aging, exercise, and extracellular matrix in the heartEpithelial-mesenchymal transition in colorectal cancer tissue of patients with Lynch syndrome.Extracellular matrix-mediated cellular communication in the heart.P2X7 receptor antagonism modulates IL-1β and MMP9 in human atherosclerotic vesselsNew Insights into the Role of Matrix Metalloproteinases in Preeclampsia.Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke.Azygous Vein Aneurysm (AVA): A Case ReportZymography as a Research Tool in the Study of Matrix Metalloproteinase Inhibitors.All vessels are not created equal.Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.Systemic Delivery of Nanoparticles Loaded with Pentagalloyl Glucose Protects Elastic Lamina and Prevents Abdominal Aortic Aneurysm in Rats.Strategies to Target Matrix Metalloproteinases as Therapeutic Approach in Cancer.Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.The Role of Angiogenesis in Cancer Treatment.Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.Role of Exercise-Induced Cardiac Remodeling in Ovariectomized Female Rats.Beneficial Role of Rosuvastatin in Blood-Brain Barrier Damage Following Experimental Ischemic Stroke
P2860
Q26850781-06465E8E-057B-45FB-A448-71C3E8EA21DEQ34795399-0F44A08C-B809-4CB3-B023-ADCCE467CC32Q35088395-D3F5131D-E317-4DCD-ABFB-F0774EE89390Q35116422-418F8925-2CB2-4366-80BB-3F02DF95A88DQ35302906-28BD2EC1-BEF0-4F7F-B956-41CC4026F633Q36064768-16326245-8895-463B-9E7C-C724E8F657F3Q36316444-E2A4E160-0D40-4ACE-9761-D4CDCD9A7994Q36644577-3F208905-D23A-4C75-81FF-19A540CB64DEQ36748065-DE879580-DAD0-44B1-BBE2-E9703C8C327EQ36910638-70D87BA1-E0D1-4A7A-90C6-3AE8FFE75BE3Q36960275-5CA880EB-8EBA-425A-89BD-0F9F9428E7A5Q37010509-A629BC1C-0BF0-4E32-9A5C-89D603E92B97Q37141033-4661BFB2-906D-420D-BEF5-1CF1AF7537E0Q37332371-61894128-8F49-4FAB-B4B8-60E1B2731C5FQ37454482-D80B9078-463B-414D-9C7E-67E6E3BC4BB3Q38632188-C91D94EE-A92A-463F-A366-C88DC1A1B025Q38688810-18F546C8-DE5E-47F5-9B44-92BBED794E3BQ39447253-87EC888D-43BA-4061-8EF5-80E0572CE7FEQ41678549-083DFA1F-307D-46DD-A60E-C3F66F204966Q42293059-C5B30972-8251-47C1-A7BB-6C9AA71AF2C3Q47117984-67665EF7-D4DE-462B-9299-B16CA24D4F69Q47179466-4D73A37E-DDAD-431A-9B32-FF387F86744AQ47223491-0DC7E71E-D5CD-4AB1-918B-84C3908956CFQ48104140-174663C1-9BAE-4EC3-A5AB-1B8AB9AA65D2Q50109651-CC13ACBE-5161-406C-81CA-FAF5FD26A87EQ50916304-84ACC392-6B75-4478-9078-F9BA54FBF08BQ50932310-1964D988-9588-4502-AB40-EA3A3DA1B57BQ51055817-E47C9870-7545-4FFE-A2AB-FCF7AB21B32AQ52691020-5D1888E8-0617-4A67-BF20-745CED29B915Q58729274-BC9F8803-0884-4401-AB77-C3E09A410CE8
P2860
Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Matrix metalloproteinase inhib ...... anagement of vascular disease.
@ast
Matrix metalloproteinase inhib ...... anagement of vascular disease.
@en
type
label
Matrix metalloproteinase inhib ...... anagement of vascular disease.
@ast
Matrix metalloproteinase inhib ...... anagement of vascular disease.
@en
prefLabel
Matrix metalloproteinase inhib ...... anagement of vascular disease.
@ast
Matrix metalloproteinase inhib ...... anagement of vascular disease.
@en
P2860
P1433
P1476
Matrix metalloproteinase inhib ...... anagement of vascular disease.
@en
P2093
Mina M Benjamin
Raouf A Khalil
P2860
P304
P356
10.1007/978-3-0348-0364-9_7
P577
2012-01-01T00:00:00Z